US5326568A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of tissue-specific delivery
Assignee: Individual
•
Filing: 1992-04-30
•
Granted: 1994-07-05
•
Expires: 2012-04-30
Abstract
Abstract The method of tissue-specific delivery of therapeutic agents via a bio-oncotic pump which includes the steps of furnishing an implantable element which is biodegradable in situ within human tissue. Such an element defines a series of respective concentric shells having different therapeutic agents disposed upon each of the shells such that the outermost shell and associated agents will be delivered earliest, while the innermost shell and its agents will be delivered last. The material of the biodegradable element is selected from the group of materials including processed sheep dermal collagen, Hench's bioglass, fibrinogen, polyimino-carbonate, and polylactic acid. A vaso-inductive agent is integrated into the surface of the element. Selected groups of therapeutic agents are incorporated into the element, which is followed by the subcutaneous implantation and securing of said element into the human tissue at the site of interest. Following implantation of the element, the vaso-inductive agent will stimulate capillary growth to facilitate delivery of the therapeutic agent to the tissue specific site.
Inventors
- 👤 Vincent C. Giampapa
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 22:55
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61M; A61M31/00; A61M31/002; Y; Y10; Y10S; Y10S623/00; Y10S623/915; Y10S707/00; Y10S707/912; Y10S707/942; Y10S707/99931; Y10S707/99933; Y10S707/99934
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
197 words
A method of bio-oncotic tissue-specific delivery of therapeutic agents, comprising the steps of: (a) furnishing an implantable element that is biodegradable in situ within human tissue, said implantable element defining a series of respectively concentric shells having said therapeutic agents incorporated upon or within each of said shells such that the outermost shell and said agents associated therewith will be delivered earliest while the innermost shell and its agents will be delivered last within said human tissue, said agents to be delivered selected from the group consisting essentially of chemotherapeutics, analgesics, hormones, enzymes, anesthetics, anti-inflammatories, antibiotics, and immunoglobulins, and the material of said biodegradable element selected from the group consisting essentially of processed sheep dermal collagen, Hench's bioglass, fibrinogen, polyimino-carbonates, and polylactic acid; (b) integrating into a surface of said element a vaso-inductive agent selected from the group consisting essentially of vascular endothelial growth factor, platelet growth factor, vascular permeability growth factor, fibroblast growth factor, and transforming growth factor beta; and (c) subcutaneously implanting and securing said element into said tissue, whereby, following implantation of said element into said tissue, said vaso-inductive agent will stimulate capillary growth thereby facilitating delivery of said therapeutic agents to said tissue.
Claim 2
Independent Claim
197 words
A method of bio-oncotic tissue-specific delivery of therapeutic agents, comprising the steps of: (a) furnishing an implantable element that is biodegradable in situ within human tissue, said implantable element defining a series of respectively concentric shells having said therapeutic agents incorporated upon or within each of said shells such that the outermost shell and said agents associated therewith will be delivered earliest while the innermost shell and its agents will be delivered last within said human tissue, said agents to be delivered selected from the group consisting essentially of chemotherapeutics, analgesics, hormones, enzymes, anesthetics, anti-inflammatories, antibiotics, and immunoglobulins, and the material of said biodegradable element selected from the group consisting essentially of processed sheep dermal collagen, Hench's bioglass, fibrinogen, polyimino-carbonates, and polylactic acid; (b) integrating into a surface of said element a vaso-inductive agent selected from the group consisting essentially of vascular endothelial growth factor, platelet growth factor, vascular permeability growth factor, fibroblast growth factor, and transforming growth factor beta; and (c) subcutaneously implanting and securing said element into said tissue, whereby, following implantation of said element into said tissue, said vaso-inductive agent will stimulate capillary growth thereby facilitating delivery of said therapeutic agents to said tissue.
Claim 3
Dependent Claim
34 words
The method as recited in claim 1, in which said implantable element furnishing step (a) comprises: providing a planar substrate rolled spirally upon an axis thereof to approximate the external geometry of a cylinder.
Claim 4
Dependent Claim
60 words
The method as recited in claim 1 in which said implantable element furnishing Step (a) comprises: furnishing a series of respectively concentric shells having different therapeutic agents disposed upon each of said shells such that the outermost shell and associated agents will be delivered earliest while the innermost shell and its agents will be delivered last to the human tissue.
Claim 5
Dependent Claim
24 words
The method as recited in claim 3, further comprising the step of: (e) providing further vasoinductive agents disposed between each of said concentric shells.
Claim 6
Dependent Claim
22 words
The method as recited in claim 3, in which said step of furnishing concentric shells comprises the step of: furnishing concentric tubules.
Claim 7
Dependent Claim
24 words
The method as recited in claim 5, further comprising the step of: (f) providing further vasoinductive agents disposed between each of said concentric tubules.
Claim 8
Dependent Claim
23 words
The method as recited in claim 1, in which said integrating Step (b) comprises: use of an angiogenic agent as said vasoinductive agent.
References Cited (Backward Citations)
US3625214A
Cited
DE2424169A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-07-04 | 1998-01-03 | 1998-07-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-07-04 | 2002-01-03 | 2002-07-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-07-04 | 2006-01-03 | 2006-07-05 | $7700.00 | Window Closed / Lapsed |